1: Brás A, Rodrigues AS, Rueff J. Copy number variations and constitutional
chromothripsis (Review). Biomed Rep. 2020 Sep;13(3):11. doi:
10.3892/br.2020.1318. Epub 2020 Jun 26. PMID: 32765850; PMCID: PMC7391299.
2: Gomes BC, Rueff J, Rodrigues AS. MicroRNAs and Cancer Drug Resistance.
Methods Mol Biol. 2016;1395:137-62. doi: 10.1007/978-1-4939-3347-1_9. PMID:
26910073.
3: Rodrigues AS, Dinis J, Gromicho M, Martins C, Laires A, Rueff J. Genomics and
cancer drug resistance. Curr Pharm Biotechnol. 2012 Apr;13(5):651-73. doi:
10.2174/138920112799857549. PMID: 22122479.
4: Brás A, Rodrigues AS, Gomes B, Rueff J. Down syndrome and microRNAs. Biomed
Rep. 2018 Jan;8(1):11-16. doi: 10.3892/br.2017.1019. Epub 2017 Nov 17. PMID:
29403643; PMCID: PMC5780767.
5: Léonard A, Gerber GB, Stecca C, Rueff J, Borba H, Farmer PB, Sram RJ, Czeizel
AE, Kalina I. Mutagenicity, carcinogenicity, and teratogenicity of
acrylonitrile. Mutat Res. 1999 May;436(3):263-83. doi:
10.1016/s1383-5742(99)00006-x. PMID: 10354525.
6: Rueff J, Weixler B, Viehl CT, Ochsner A, Warschkow R, Gueller U, Mingrone W,
Zuber M. Improved quality of colon cancer surveillance after implementation of a
personalized surveillance schedule. J Surg Oncol. 2020 Sep;122(3):529-537. doi:
10.1002/jso.25973. Epub 2020 May 14. PMID: 32410263.
7: Rueff J, Rodrigues AS. Cancer Drug Resistance: A Brief Overview from a
Genetic Viewpoint. Methods Mol Biol. 2016;1395:1-18. doi:
10.1007/978-1-4939-3347-1_1. PMID: 26910065.
8: Rueff J, Rodrigues AS, Kranendonk M. A personally guided tour on some of our
data with the Ames assay-A tribute to Professor Bruce Ames. Mutat Res Genet
Toxicol Environ Mutagen. 2019 Oct;846:503094. doi:
10.1016/j.mrgentox.2019.503094. Epub 2019 Sep 9. PMID: 31585631.
9: Rodrigues AS, Oliveira NG, Gil OM, Léonard A, Rueff J. Use of cytogenetic
indicators in radiobiology. Radiat Prot Dosimetry. 2005;115(1-4):455-60. doi:
10.1093/rpd/nci072. PMID: 16381766.
10: Gomes BC, Honrado M, Armada A, Viveiros M, Rueff J, Rodrigues AS. ABC Efflux
Transporters and the Circuitry of miRNAs: Kinetics of Expression in Cancer Drug
Resistance. Int J Mol Sci. 2020 Apr 23;21(8):2985. doi: 10.3390/ijms21082985.
PMID: 32340269; PMCID: PMC7215654.
11: Calado J, Santer R, Rueff J. Effect of kidney disease on glucose handling
(including genetic defects). Kidney Int Suppl. 2011 Mar;(120):S7-13. doi:
10.1038/ki.2010.510. PMID: 21358700.
12: S Santos L, M Gil O, N Silva S, C Gomes B, C Ferreira T, Limbert E, Rueff J.
Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid
Cancer: The Influence of DNA Repair Genes Variants. Genes (Basel). 2020 Sep
17;11(9):1083. doi: 10.3390/genes11091083. PMID: 32957448; PMCID: PMC7565468.
13: Rueff J, Gaspar J, Kranendonk M. DNA polymorphisms as modulators of
genotoxicity and cancer. Biol Chem. 2002 Jun;383(6):923-32. doi:
10.1515/BC.2002.099. PMID: 12222682.
14: Santos LS, Gomes BC, Bastos HN, Gil OM, Azevedo AP, Ferreira TC, Limbert E,
Silva SN, Rueff J. Thyroid Cancer: The Quest for Genetic Susceptibility
Involving DNA Repair Genes. Genes (Basel). 2019 Aug 1;10(8):586. doi:
10.3390/genes10080586. PMID: 31374908; PMCID: PMC6722859.
15: Martins C, Rueff J, Rodrigues AS. Genotoxic alkenylbenzene flavourings, a
contribution to risk assessment. Food Chem Toxicol. 2018 Aug;118:861-879. doi:
10.1016/j.fct.2018.06.020. Epub 2018 Jun 18. PMID: 29913232.
16: Santos LS, Silva SN, Gil OM, Ferreira TC, Limbert E, Rueff J. Mismatch
repair single nucleotide polymorphisms and thyroid cancer susceptibility. Oncol
Lett. 2018 May;15(5):6715-6726. doi: 10.3892/ol.2018.8103. Epub 2018 Feb 21.
PMID: 29616133; PMCID: PMC5876466.